Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγ

Mirjam E Hoekstra1, Laura Bornes2, Feline E Dijkgraaf1

  • 1Division of Molecular Oncology & Immunology, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

Nature Cancer
|June 23, 2020
PubMed

Insights

Activated CD8+ T cells secrete interferon-gamma (IFNγ), which spreads widely within tumors, influencing distant tumor cells. This immune response can increase PD-L1 and inhibit tumor growth, even in antigen-loss variants.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Interferon-gamma (IFNγ) secreted by CD8+ T cells has known effects on tumor cells, including immune checkpoint induction and growth inhibition.
  • The spatial and temporal dynamics of IFNγ spread within the tumor microenvironment remain poorly understood.

Purpose of the Study:

  • To investigate the spatiotemporal spreading of IFNγ secreted by activated CD8+ T cells within a tumor.
  • To determine if long-range IFNγ signaling affects tumor cell behavior and growth.

Main Methods:

  • Multiday intravital imaging of tumors.
  • Analysis of IFNγ spread in tumors with spatially separated antigen-positive and -negative tumor cells.

Main Results:

  • IFNγ secreted by a small fraction of recognized tumor cells is sensed by a large portion of the tumor mass.
  • IFNγ response spreads over distances exceeding 800 µm.
  • Long-range IFNγ signaling induces PD-L1 expression and inhibits tumor growth.

Conclusions:

  • CD8+ T cell-secreted IFNγ modulates the behavior of remote tumor cells, including antigen-loss variants.
  • IFNγ plays a crucial role in coordinating anti-tumor immunity across the tumor landscape.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K